Your Source for Venture Capital and Private Equity Financings

Venture Capital News: BioScale Weighs in with $5.2M Venture Debt

2012-03-06
LEXINGTON, MA, Maker of protein analysis technology raised $5.2 million in convertible debt.
BioScale, a maker of protein measurement technology, disclosed in SEC filings that it has raised $5.2 million in convertible debt. 37 separate investors participated in the offering.

BioScale was founded in 2002 by CEO Mark Lundstrom and three interdisciplinary MIT professors. Since then the Company has assembled development, engineering, manufacturing and an industry-seasoned commercial team to globally launch its AMMP assay technology and ViBE platform into the pharmaceutical, biotech, life science, and bioprocess markets. We are also pursuing partnering for diagnostic and specialty applications. The company's new 30,000 sq. ft. global headquarters and manufacturing site are located in Lexington, Massachusetts.

(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors